好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | CTMC - NIH-NINDS Clinical Trials Methodology Course

Monday 04/20/26
04:00 PM - 04:30 PM CDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Laurie Gutmann, MD, FAAN, Christopher Coffey, PhD, FAAN, Robin A. Conwit, MD, FAAN, Mark S. Quigg, MD
好色先生, Research, and Methodology
Do you want to improve your clinical trial knowledge? Come learn about the NIH-NINDS Clinical Trials Methodology Course (CTMC)! The program's goal is to train early career investigators to develop scientifically rigorous, feasible, and ethically designed clinical trials. CTMC teaches best practices in trial design from experienced neurological clinical trialists and biostatisticians. 
No CME available
Event Timeline
No timeline events available at this time.
Faculty Disclosures
Laurie Gutmann, MD, FAAN The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Christopher Coffey, PhD, FAAN Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Robin A. Conwit, MD, FAAN Dr. Conwit has nothing to disclose.
Mark S. Quigg, MD Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.